Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Cancer (BTC)”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Not applicableLooking for participantsNCT07326137
What this trial is testing

A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain

Who this might be right for
Advanced Biliary Tract Cancer(BTC)Advanced Pancreatic CancersCancer-related Pain
Tongji Hospital 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT06490107
What this trial is testing

Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC

Who this might be right for
Biliary Tract Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04217954
What this trial is testing

HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

Who this might be right for
Advanced Biliary Tract Cancer
Peking University 32
Early research (Phase 1)Ended earlyNCT01949870
What this trial is testing

Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

Who this might be right for
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
AstraZeneca 6
Not applicableLooking for participantsNCT07101874
What this trial is testing

Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients

Who this might be right for
Biliary Tract Cancer
AstraZeneca 1,000
Testing effectiveness (Phase 2)UnknownNCT05653180
What this trial is testing

IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Innovent Biologics (Suzhou) Co. Ltd. 20
Testing effectiveness (Phase 2)UnknownNCT01811277
What this trial is testing

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Who this might be right for
Biliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer
Peking University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05733598
What this trial is testing

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Cancer
Replimune Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT02992340
What this trial is testing

Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC

Who this might be right for
Biliary Tract Cancer
ASLAN Pharmaceuticals 204
Large-scale testing (Phase 3)Looking for participantsNCT07229625
What this trial is testing

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

Who this might be right for
Advanced Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 604
Testing effectiveness (Phase 2)Study completedNCT02386397
What this trial is testing

Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Digestive Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 66
Testing effectiveness (Phase 2)Study completedNCT02579616
What this trial is testing

Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy

Who this might be right for
Biliary Tract Cancer
Eisai Co., Ltd. 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT06074029
What this trial is testing

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

Who this might be right for
Biliary Tract CancerImmune Checkpoint InhibitorPredictive Cancer Model
Peking Union Medical College Hospital 50
Early research (Phase 1)Looking for participantsNCT07197554
What this trial is testing

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid TumorsEwing SarcomaHepatocellular Carcinoma (HCC)+1 more
SEED Therapeutics, Inc. 171
Testing effectiveness (Phase 2)UnknownNCT05410197
What this trial is testing

Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)

Who this might be right for
Advanced Biliary Tract Cancer
Sun Yat-sen University 43
Large-scale testing (Phase 3)Study completedNCT04924062
What this trial is testing

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study

Who this might be right for
Biliary Tract Carcinoma
Merck Sharp & Dohme LLC 158
Not applicableNot Yet RecruitingNCT07142226
What this trial is testing

Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC

Who this might be right for
Biliary Tract Cancer
CHA University 200
Testing effectiveness (Phase 2)Looking for participantsNCT06320301
What this trial is testing

Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)

Who this might be right for
Biliary Tract CancerGemox Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 43
Large-scale testing (Phase 3)Study completedNCT04003636
What this trial is testing

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

Who this might be right for
Biliary Tract Carcinoma
Merck Sharp & Dohme LLC 1,069
Not applicableLooking for participantsNCT06893380
What this trial is testing

Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer

Who this might be right for
Locally Advanced Biliary Tract CancersMetastatic Biliary Tract Cancers
CHA University 61
Load More Results